[go: up one dir, main page]

Kategaya et al., 2017 - Google Patents

USP7 small-molecule inhibitors interfere with ubiquitin binding

Kategaya et al., 2017

View PDF
Document ID
3257165405221753454
Author
Kategaya L
Di Lello P
Rougé L
Pastor R
Clark K
Drummond J
Kleinheinz T
Lin E
Upton J
Prakash S
Heideker J
McCleland M
Ritorto M
Alessi D
Trost M
Bainbridge T
Kwok M
Ma T
Stiffler Z
Brasher B
Tang Y
Jaishankar P
Hearn B
Renslo A
Arkin M
Cohen F
Yu K
Peale F
Gnad F
Chang M
Klijn C
Blackwood E
Martin S
Forrest W
Ernst J
Ndubaku C
Wang X
Beresini M
Tsui V
Schwerdtfeger C
Blake R
Murray J
Maurer T
Wertz I
Publication year
Publication venue
Nature

External Links

Snippet

The ubiquitin system regulates essential cellular processes in eukaryotes. Ubiquitin is ligated to substrate proteins as monomers or chains and the topology of ubiquitin modifications regulates substrate interactions with specific proteins. Thus ubiquitination …
Continue reading at discovery.dundee.ac.uk (PDF) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/978—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/902—Oxidoreductases (1.)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions

Similar Documents

Publication Publication Date Title
Kategaya et al. USP7 small-molecule inhibitors interfere with ubiquitin binding
Johansson et al. Structural analysis of human KDM5B guides histone demethylase inhibitor development
Cheng et al. Discovery of potent and selective epidermal growth factor receptor (EGFR) bifunctional small-molecule degraders
Guo et al. Enhancing intracellular accumulation and target engagement of PROTACs with reversible covalent chemistry
Schauer et al. Selective USP7 inhibition elicits cancer cell killing through a p53-dependent mechanism
Lamberto et al. Structure-guided development of a potent and selective non-covalent active-site inhibitor of USP7
Patricelli et al. Selective inhibition of oncogenic KRAS output with small molecules targeting the inactive state
Quinlan et al. Targeting S-adenosylmethionine biosynthesis with a novel allosteric inhibitor of Mat2A
Li et al. Capzimin is a potent and specific inhibitor of proteasome isopeptidase Rpn11
He et al. The EED protein–protein interaction inhibitor A-395 inactivates the PRC2 complex
Mullarky et al. Identification of a small molecule inhibitor of 3-phosphoglycerate dehydrogenase to target serine biosynthesis in cancers
Fan et al. Covalent disruptor of YAP-TEAD association suppresses defective Hippo signaling
Kok et al. Discovery of small-molecule enzyme activators by activity-based protein profiling
Feng et al. K-RasG12D has a potential allosteric small molecule binding site
Sivakumaren et al. Targeting the PI5P4K lipid kinase family in cancer using covalent inhibitors
US20230381180A1 (en) Small molecule modulators of ksr-bound mek
Zheng et al. Strain-release alkylation of Asp12 enables mutant selective targeting of K-Ras-G12D
Darabedian et al. Depletion of creatine phosphagen energetics with a covalent creatine kinase inhibitor
Fabini et al. Small-molecule inhibitors of lysine methyltransferases SMYD2 and SMYD3: current trends
Mo et al. Neddylation requires glycyl-tRNA synthetase to protect activated E2
Zhou et al. Selective inhibition of cullin 3 neddylation through covalent targeting DCN1 protects mice from acetaminophen-induced liver toxicity
Sato et al. Structural basis of the regulation of the normal and oncogenic methylation of nucleosomal histone H3 Lys36 by NSD2
Bata et al. Inhibitors of the Hippo pathway kinases STK3/MST2 and STK4/MST1 have utility for the treatment of acute myeloid leukemia
Hu et al. Electrophilic probes for deciphering substrate recognition by O-GlcNAc transferase
Yu et al. Phenotype-based screens with conformation-specific inhibitors reveal p38 gamma and delta as targets for HCC polypharmacology